We believe that every person with ALS is needed to advance research toward treatments and cures. Participating
in PMP 2.0 will allow your data to achieve this goal. And by enrolling, you become
a partner in research and will have access to your data and other data as part of the program. Become a
partner with the world's first and most prestigious precision medicine program, and you will
directly impact the pace at which we advance treatments into clinical trial.
I want to sign up for PMP 2.0
PMP 2.0 is an extension of the Precision Medicine Program at
the ALS Therapy Development Institute. If you are already enrolled in the
PMP, you do not need to enroll
in PMP 2.0.
PMP 2.0 is designed based on observations made in the program already that
signal the opportunity to advance subtype identification by adding data from more and more people with
ALS. PMP data may also be used to understand the potential use of wearable
technology as a tool to accelerate all ALS clinical trials; something, which is globally accepted by
the ALS medical research community as an urgent need. With PMP 2.0 we aim
to collect the following as quickly as possible:
The graphs below show our progress towards this aim.